AHP goes beyond

AHP Goes Beyond…

AHP Goes Beyond

Virox® Technologies Inc. is proud to announce that its patented Accelerated Hydrogen Peroxide® (AHP® ) disinfectant and cleaning technology under the brand name PREempt™ was approved for use as the first Accelerated Hydrogen Peroxide® (AHP®) based technology aboard the International Space Station.

“The overwhelming acceptance of the Virox® AHP® disinfection technology in human and animal health by key opinion leaders and leading edge facilities charged with protecting patients, is a testimony to the credibility of our efficacy claims. Now with NASA taking our AHP® disinfectants into outer space to combat both known and unknown pathogens, that credibility has hit new heights and we couldn’t be more proud” says Randy Pilon, President and CEO.


Virox® believes there is no longer the need to compromise on efficacy of application, or to trade off for either personal safety or environmental integrity. “It is a moment of pride for the development team to see our technology out of this world, orbiting around the earth 15 times per day! To us this is a major testament on the superiority of our technology platform” says Faraz Ahmadpour, Senior Vice President of R&D and Open Innovation.


It has long been known that hydrogen peroxide can kill pathogens without being harmful to the user. AHP® is a synergistic blend of commonly used, safe ingredients that when combined with low levels of hydrogen peroxide dramatically increases its germicidal potency and cleaning performance. AHP® contains only those ingredients listed on the U.S.A. EPA inert listing, the GRAS (Generally Regarded As Safe) listing published by the United Food & Drug Administration (FDA), and the CleanGredients list, which contributes to an unsurpassed health, safety and environmental profile.


Virox Technologies Inc.® is focused on equipping the entire spectrum of global markets with state-of-the-art antimicrobial technology in the war against pathogens. Our company is dedicated to the development, optimization, and adaptation of a deliberately different approach to this challenge – an approach that has been validated and endorsed by the scientific community, and has been adopted by market leaders in a broad range of industries.


Source: Virox Technologies Inc.®


For further information: John Van Dyke, SVP Corporate Marketing, 1-800-387-7578, jvandyke@virox-corp.bold-staging.com

You may also like